Related Experiment Video
Updated: Jun 30, 2026

Fentanyl Analog Screening using LC-TIMS-TOF MS/MS
Published on: November 8, 2024
Trends and circumstances of pediatric fentanyl deaths in North Carolina: a 10-year retrospective study
Meredith Welch1, Laura W Friederich1, Mary E Cox2
1North Carolina Office of the Chief Medical Examiner, Raleigh, NC 27607, United States.
Insights
Fentanyl deaths in North Carolina children (0-17 years) were analyzed, revealing higher rates in very young children and older adolescents. Key factors included co-sleeping, drug access in homes, and substance use history in older teens.
Area of Science:
- Forensic Science
- Public Health
- Toxicology
Background:
- Fentanyl overdose deaths are a growing concern among adolescents and children.
- Understanding the specific circumstances surrounding pediatric fentanyl deaths is crucial for prevention.
Purpose of the Study:
- To analyze contextual factors and scientific data of fentanyl-related deaths in North Carolina individuals aged 0-17 years from 2015-2024.
- To identify age-specific trends and risk factors associated with pediatric fentanyl fatalities.
Main Methods:
- Utilized data from the North Carolina Medical Examiner System (2015-2024).
- Manually abstracted scene information, toxicology results, and pathological findings for 138 pediatric fentanyl deaths.
- Analyzed demographic data, overdose onset locations, co-sleeping incidents, substance use history, and postmortem blood fentanyl concentrations.
Main Results:
- Identified 138 pediatric fentanyl deaths, with higher rates in children under two and adolescents aged 15-17.
- For children under two, 78.8% of overdoses occurred at home, 60.6% involved co-sleeping in adult beds, and 51.5% had drugs/paraphernalia present.
- For adolescents, 62.5% of overdoses occurred at home, 82.5% had a history of substance use, and 67.5% had drugs/paraphernalia present.
Conclusions:
- Specific trends like co-sleeping with drug access in young children and counterfeit pharmaceuticals in adolescents highlight areas for targeted prevention.
- Age-specific overdose prevention strategies are needed, informed by detailed medicolegal death investigations.
- Enhanced workflows for pediatric death investigation and electronic reporting are being implemented.
Abstract:
This study describes the contextual factors and scientific data associated with fentanyl-related deaths among individuals aged 0-17 years in North Carolina. Using information from the North Carolina Medical Examiner System from 2015 to 2024, 138 pediatric fentanyl deaths were identified. Manually abstracted scene information, toxicology results, and pathological findings allowed for a rarely examined in-depth analysis of circumstances surrounding these deaths. Children less than 2 years (n = 33, 1.38 per 100 000) and adolescents aged 15-17 years (n = 80, 1.96 per 100 000) experienced a fentanyl-related death rate higher than the statewide pediatric fentanyl-related death rate of 0.60 per 100 000 residents. Among children less than 2 years, 78.8% of overdose onset occurred in the decedent's primary residence, and drugs or paraphernalia were present at the scene in 51.5% of cases. Co-sleeping was documented in 60.6% of deaths, with 80.0% occurring in adult beds. Postmortem blood concentrations of fentanyl among children less than two years ranged from less than 0.50 to 280 ng/mL (mean 27.0 ng/mL, median 17 ng/mL). Among adolescents, 62.5% of overdose onset occurred in the decedent's primary residence, followed by a friend's residence (13.8%). History of substance use was documented in 82.5% of cases and drugs or paraphernalia were present in 67.5% of cases. Blood concentrations of fentanyl among adolescents ranged from less than 1.0 to 330 ng/mL (mean 21.7 ng/mL, median 11.0 ng/mL). Scene investigation and documentation allow for the recognition of behavioral trends, which can be targeted for age-specific overdose prevention strategies. Among decedents less than 2 years, notable trends included children co-sleeping in adult beds with access to drugs and drug waste and/or prolonged periods without supervision. Among older adolescents, several cases involved suspected counterfeit pharmaceuticals and/or periods of non-contact with primary caregivers. Improved workflows for pediatric medicolegal death investigation and electronic reporting strategies are already underway.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmaceutical Poisoning: Potential Scenarios
Pharmacokinetics in Pediatric Patients: Drug Distribution
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Drug Toxicity: Risk factors
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption